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Abstract
Objective: To assess the referral practice for surveillance colonoscopy amongst 
clinicians and to measure whether practice was inline with the current Association of 
Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of 
Gastroenterology (BSG) guidelines. Methods: A questionnaire was sent to members 
of the ACPGBI. Results: A total of 195 (49%) clinicians responded, providing 
information on their referral habits with comments on where they deviated from the 
guidelines. Conclusions: The BSG and ACPGBI guidelines are well established 
amongst clinicians and generally accepted as best practice however the majority of 
clinicians deviate from the guidelines for particular clinical scenarios. In fact only 
18% of respondents followed all recommendations for surveillance colonoscopy for 
patients with polyps, previous cancers and a family history. 
Introduction
In 2002, the Association of Coloproctology of Great Britain and Ireland (ACPGBI) 
and the British Society of Gastroenterology (BSG) released a comprehensive list of 
recommendations for surveillance colonoscopy of high-risk groups1. The aim of this 
study was to assess the referral practice for surveillance colonoscopy amongst
clinicians and measure whether practice was inline with the current guidelines. 
Materials and Methods
In 2006, a questionnaire (see Appendix) was sent to 400 members of the Association 
of Coloproctology of Great Britain and Ireland via a posted-circular. In addition to 
information on their referral habits, the clinicians were asked to give comments and/or 
define where they deviated from the guidelines.
Results
A total of 195 (49%) clinicians responded. The majority of responders were 
consultants (193, 99%) and from surgical specialities (180, 92%). 96% (188) were 
practising colonoscopists. Very few respondents agreed with all the guidelines, but 
colonoscopists varied in which guidelines they chose to follow.
Polyp Follow Up: Of the responders, 179 (92%) followed the guidelines for 
surveillance after high-risk polyps. With 184 (94%) and 166 (85%) following the 
guidelines for medium- and low- risk polyps respectively (Figure 1). The exceptions 
and comments provided by respondents associated with adenomatous polyps are 
summarized in table 1. 
Cancer Follow Up: Some 144 (74%) respondents screened patients with a previous 
colorectal cancer (CRC) five yearly as recommended in the guidelines, with 51 (26%) 
stating they scoped more frequently. Only 64 (32%) ceased surveillance at the age of 
70 years. Of those who said they would scope patients past the age of 70: - 33 would 
scope to 75 years; 28 to 80 years; 2 to 85 years; and 44 until the patient was “too 
frail” (Figure 2).  
Family History Follow Up: 176 (90%) were happy to start performing colonoscopy on 
patients with at least one first degree relative, under the age of 45 years, at the age of 
35-40 years however only 108 (55%) would wait to re-scope at the age of 55. 
Likewise, 169 (87%) would begin scoping those patients with at least two FDR, of 
any age, at 35-40 years but only 114 (58%) would wait until the age of 55 years for 
the second surveillance colonoscopy. Almost half of respondents felt it more 
appropriate to scope patients with a family history of colorectal cancer every five 
years. Many respondents would seek the advice of their local genetic services.
Only 18% of respondents followed all the ACPGBI and BSG recommendations for 
surveillance colonoscopy for patients with polyps, previous cancers and a family 
history.
Discussion
Colonoscopy is the current gold standard for examination of colonic surfaces 2. It is 
well established that regular colonoscopic surveillance of the bowel may allow early 
detection of CRC in high-risk groups 3-8, even though one study captured 80% non 
compliance shortly after publication of the national  guidelines9. The USA National 
Polyp Study observed the incidence of CRC in patients undergoing colonoscopic 
surveillance was 70-90% lower than expected compared with three reference 
populations10. Four years after the ACPGBI and BSG released their guidelines for 
colonoscopic surveillance1 almost all respondents said their normal practice was to 
follow some of the BSG/ ACPGBI guidelines when referring patients for surveillance 
colonoscopy, with all respondents being aware of the guidelines. 
As far as we are aware this is the only study that examines the referral habits of 
colonoscopists across the country since the publication of the guidelines1. The overall 
response rate was reasonably high which we attribute the support offered by the 
ACPGBI. The main limitation of the study is the lack of data on the non-responders. 
As this was an anonymous questionnaire survey further information from the 
clinicians is not possible. We also contacted the British Society of Gastroenterology 
who sent the questionnaire to 2000 members of the via the delegate packs at the 
Society’s annual meeting in Birmingham. We only received 13 responses (0.65%) 
therefore the data is not included in this study. Questionnaires in delegate packs at 
large international conference is not a successful data collection method.
Overall, fewer respondents agreed with following up low-risk sigmoid adenomas 
compared to the recommendations for the high- and medium– risk adenomas. The 
majority of those who said they do not scope five yearly but preferred to scope more 
regularly. 
Two thirds of all clinicians did not want to cease surveillance of cancer or polyp 
patients at the specified age. The cut off age is set at 70 years for patients with a 
previous cancer and 75 years for those patients with polyps as the remaining life 
expectancy is likely to be less than the average time required for new adenoma to 
become malignant2. With our aging population in Britain, clinicians reluctance to 
limit surveillance by age may be justified.
Two respondents commented on concerns of the reliability of patients being able to 
give a full, accurate family history of colorectal cancer. Aitken et al (1995)11
conducted a study to validate the self-reported family histories of colorectal cancer of 
237 patients undergoing colonoscopy. They confirmed positive family histories in 
77% of cases and estimated 98% of the negative family histories were correct11.
Guidelines are seen by many as simply recommendations for practice by central 
organisations with the final decisions remaining with the treating clinician. High level 
of acceptance of these guidelines, for duration and frequency of surveillance 
colonoscopy, does hold the promise national acceptance thereby preventing postcode 
treatment. Three consultants referred to local guidelines within their trust and one 
reported he followed the American Societie’s guidelines. These findings raise some 
interesting questions regarding practise outside recommendations of central 
organisations and informed consent of patients. With a perforation rate of 0.2%12 13 as 
well as other risks including bleeding, infection etc; in the event of a complication, an 
informed lawyer would find it easy to attack a clinician operating outside well-
established national guidelines. Interestingly, several practitioners stated lack of 
capacity and/or daunting waiting lists as factors preventing them performing 
colonoscopies at frequencies the would like or within the guidelines’ 
recommendations. 
To conclude, although the BSG and ACPGBI guidelines are well established amongst 
clinicians and generally accepted as best practice. However less than 1/5th of the 
clinicians who responded follow all the guidelines. Perhaps the decision to perform 
each colonoscopy must also take into account the wishes of the individual patient, the 
presence of co-morbidity, local guidelines and other risk factors associated with the 
procedure. We believe that education of the guidelines among clinicians and nurses in 
the endoscopy department may improve uptake of guidelines and improve patient 
services. 
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